The Anheuser-Busch InBev S.A. ADR slid 3.21% to $50.11 Wednesday, on what proved to be an all-around poor trading session for ...

The Anheuser-Busch InBev S.A. ADR inched 0.22% higher to $50.21 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.09% to 5,930.85 ...

On Thursday, Canaan Inc – ADR (CAN) stock saw a decline, ending the day at $2.31 which represents a decrease of $-0.28 or -10.81% from the prior close of $2.59. The stock opened at $2.66 and touched a ...

The films of 2024 left Us with some incredible moments that made Us laugh, cry and ponder the meaning of life. Others, ...

The BioNTech SE ADR BNTX advanced 2.78% to $117.39 Tuesday, on what proved to be an all-around rough trading session for the ...

ADR (ARM) stock saw a decline, ending the day at $132.1 which represents a decrease of $-4.46 or -3.27% from the prior close of $136.56. The stock opened at $137.01 and touched a low of $131.95 during ...

For your consideration, here is a quick, year-end recap of some of the most widely read Alternative Dispute Resolution and ...

Hamilton County introduces an ADR program for family law disputes, enhancing affordability and case resolution.

Ltd (ADR) trading resumesPick the best stocks and maximize your portfolio:Discover top-rated stocks from highly ranked ...

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Structure Therapeutics, Inc. Sponsored ADR (GPCR – Research Report), with a price target of $93.00.